BackInovio Pharmaceuticals Overview

Inovio Pharmaceuticals Total Assets

Inovio Pharmaceuticals's total assets is $50B.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$49.78B
42.96% YoYΔ $-37.50B vs prior year quarter

Peer average

Loading

Inovio Pharmaceuticals Total Assets History

Loading

Inovio Pharmaceuticals vs. peers: Total Assets Comparison

Loading

Inovio Pharmaceuticals Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Inovio Pharmaceuticals (INO) FAQ

As of the most recent data (March 2026), INO shows a total assets of $50B. That compares with $87B in the prior-year period — down 43.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, INO's total assets is now $50B (was $87B) — a 43.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Inovio Pharmaceuticals is outperforming or lagging.

Tracking INO's total assets over time shows whether Inovio Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $50B That compares with $87B in the prior-year period — down 43.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has Inovio Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $50B) with ownership activity and broader fundamentals.

Inovio Pharmaceuticals's total assets is $50B; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.